Liposomal Irinotecan for Pancreatic Cancer: Is It Worth It?May 22, 2024Gastrointestinal CancerGastroenterologyPatient & Survivor CarePractice Management
Subcutaneous Antifibrinolytic Reduces Bleeding After Mohs SurgeryMay 22, 2024Nonmelanoma Skin CancerMelanoma
Urine Tests Could Be ‘Enormous Step’ in Diagnosing CancerMay 22, 2024Preventive CarePractice ManagementPatient & Survivor CareCNS/Brain CancerBreast CancerDLBCLFollicular Lymphoma
Statin Use May Extend Life for Early Breast Cancer PatientsMay 21, 2024Breast CancerPatient & Survivor Care
Former UCLA Doctor Receives $14 Million in Gender Discrimination RetrialMay 21, 2024Practice ManagementDiversity in Medicine
Follow-Up Outcomes Data Often Missing for FDA Drug Approvals Based on Surrogate MarkersMay 20, 2024Mixed Topics
New Immunotherapy Combo Shows Promise for Triple-Negative Breast CancerMay 20, 2024Metastatic Breast CancerBreast CancerPatient & Survivor Care
ART Safe for Breast Cancer Survivors with BRCA1/2 MutationsMay 17, 2024Breast CancerPatient & Survivor Care
FDA Approves Tarlatamab for Extensive-Stage Small Cell Lung CancerMay 17, 2024Lung CancerMixed TopicsPractice Management
No Improvement in OS With Atezolizumab in Early Relapsing TNBCMay 17, 2024Breast CancerPatient & Survivor Care
Chatbots Seem More Empathetic Than Docs in Cancer DiscussionsMay 16, 2024Patient & Survivor CarePractice ManagementPreventive CareRenal Cell CarcinomaSarcoma & GISTBreast CancerCNS/Brain Cancer
Tucatinib-Trastuzumab Benefit ‘Remarkable’ in HER2-positive mCRCMay 16, 2024Gastrointestinal CancerGastroenterologyPatient & Survivor CareBreast Cancer
